FMR1 and hepatocellular carcinoma: CircZKSCAN1 exerted its inhibitory effect by competitively binding to the RNA binding protein (FMRP). Therefore, the Qki5-circZKSCAN1-FMRP-CCAR1-Wnt signal axis could be used as a potential therapeutic target for HCC treatment.